3020B |
Methylphenidate and Metabolite, Blood |
3020SP |
Methylphenidate and Metabolite, Serum/Plasma |
3020TI |
Methylphenidate and Metabolite, Tissue |
3020U |
Methylphenidate and Metabolite, Urine |
3045B |
Modafinil / Armodafinil, Blood |
3045SP |
Modafinil / Armodafinil, Serum/Plasma |
3055B |
Mexiletine, Blood |
3055SP |
Mexiletine, Serum/Plasma |
3092SP |
Moricizine, Serum/Plasma |
3150B |
Nicotine and Metabolite, Blood |
3150FL |
Nicotine and Metabolite, Fluid |
3150SP |
Nicotine and Metabolite, Serum/Plasma |
3150TI |
Nicotine and Metabolite, Tissue |
3150U |
Nicotine and Metabolite with Anabasine, Urine |
3227B |
Beta-Blockers Panel, Blood |
3227SP |
Beta-Blockers Panel, Serum/Plasma |
3227U |
Beta-Blockers Panel, Urine |
3371SP |
PCB Panel, Congeners, Serum/Plasma |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3976B |
Propafenone, Blood |
3976SP |
Propafenone, Serum/Plasma |